AI in the Wild

How Scite.ai is Making Science Reliable Again

Episode Summary

This week we have on Josh Nicholson, former cancer researcher & CEO of scite.ai. scite combines deep learning with a network of experts to evaluate the veracity of scientific work. With a PH.D in Cell Biology & as a former cancer researcher himself, Josh knows the challenges of drug discovery and has been dedicated to improving the industry. By building a transparent and reliable community, scite is making science reliable again.

Episode Notes

In this episode we discuss,

• The state of drug discovery in the US
• Eroom's law and the rising cost of drug research & discovery
• How the scite platform combats the research reproducibility crisis
• The growing call for transparency in healthcare
• The impact machine learning & deep learning has on science
• Conviction in your startup - advice on when to go all in
• An Ai future and what to expect
• Building a startup under various circumstances